These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 17340909

  • 1. Osteonecrosis in the jaws of patients who are using oral biphosphonates to treat osteoporosis.
    Dello Russo NM, Jeffcoat MK, Marx RE, Fugazzotto P.
    Int J Oral Maxillofac Implants; 2007; 22(1):146-53. PubMed ID: 17340909
    [No Abstract] [Full Text] [Related]

  • 2. Bisphosphonates and bisphosphonate induced osteonecrosis.
    Sawatari Y, Marx RE.
    Oral Maxillofac Surg Clin North Am; 2007 Nov; 19(4):487-98, v-vi. PubMed ID: 18088900
    [Abstract] [Full Text] [Related]

  • 3. Management of bisphosphonate-induced osteonecrosis of the jaw.
    Schilling J.
    Northwest Dent; 2008 Nov; 87(3):34-5, 37-8, 40. PubMed ID: 18663869
    [Abstract] [Full Text] [Related]

  • 4. Drug induced osteonecrosis of the jaws.
    Weeda LW.
    J Tenn Dent Assoc; 2006 Nov; 86(2):18-9. PubMed ID: 16895006
    [No Abstract] [Full Text] [Related]

  • 5. Bisphosphonates and bone...what have we learned?
    Guttenberg SA.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):769-72. PubMed ID: 18835534
    [No Abstract] [Full Text] [Related]

  • 6. CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part I: biological concepts with a review of the literature.
    Lee CY, Suzuki JB.
    Implant Dent; 2009 Dec; 18(6):492-500. PubMed ID: 20009603
    [Abstract] [Full Text] [Related]

  • 7. Bisphosphonates: a potential threat to your patients.
    Dreiman BB.
    J Indiana Dent Assoc; 2009 Dec; 84(4):4-9. PubMed ID: 16605211
    [No Abstract] [Full Text] [Related]

  • 8. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
    Ruggiero SL, Fantasia J, Carlson E.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):433-41. PubMed ID: 16997108
    [No Abstract] [Full Text] [Related]

  • 9. CTX and its role in managing patients exposed to oral bisphosphonates.
    Dodson TB.
    J Oral Maxillofac Surg; 2010 Feb; 68(2):487-8; author reply 488-9. PubMed ID: 20116729
    [No Abstract] [Full Text] [Related]

  • 10. [Bisphosphonate-associated osteonecrosis of the jaws 1].
    Allard RH, Lips P, Eekhoff EM, van Merkesteyn JP, van der Waal I.
    Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):423-7. PubMed ID: 17972610
    [Abstract] [Full Text] [Related]

  • 11. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
    American Society for Bone and Mineral Research Task Force on Osteonecrosis of the Jaw, Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley LK, McGowan J, McKee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Shum L, Silverman SL, Van Poznak CH, Watts N, Woo SB, Shane E.
    J Oral Maxillofac Surg; 2008 Jun; 66(6):1320-1; author reply 1321-2. PubMed ID: 18486811
    [No Abstract] [Full Text] [Related]

  • 12. Osteonecrosis of the jaw and biomarkers: what do we tell our patients?
    Koka S.
    Int J Oral Maxillofac Implants; 2008 Jun; 23(2):179-80. PubMed ID: 18548914
    [No Abstract] [Full Text] [Related]

  • 13. [Bisphosphonates (BP) and osteonecrosis of the jaws; continuous treatment with Bisphosphonates should be considered].
    Mawatari T.
    Clin Calcium; 2010 Nov; 20(11):1743-7. PubMed ID: 21066910
    [No Abstract] [Full Text] [Related]

  • 14. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
    Kunchur R, Need A, Hughes T, Goss A.
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
    [Abstract] [Full Text] [Related]

  • 15. Serum CTX testing.
    Schwartz HC.
    J Oral Maxillofac Surg; 2008 Jun; 66(6):1319-20; author reply 1320. PubMed ID: 18486810
    [No Abstract] [Full Text] [Related]

  • 16. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws.
    Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial SurgeonsAAOMS, Rosemont, IL 60018, USA..
    J Oral Maxillofac Surg; 2007 Mar; 65(3):369-76. PubMed ID: 17307580
    [No Abstract] [Full Text] [Related]

  • 17. Atraumatic extraction of a non-vital tooth in a patient receiving long-term oral bisphosphonates.
    Xiong M, Pearson A, Sabino M, Svoboda L, Ehlis E.
    Northwest Dent; 2010 Mar; 89(4):27-33. PubMed ID: 20860270
    [No Abstract] [Full Text] [Related]

  • 18. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
    Lazarovici TS, Mesilaty-Gross S, Vered I, Pariente C, Kanety H, Givol N, Yahalom R, Taicher S, Yarom N.
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033
    [Abstract] [Full Text] [Related]

  • 19. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
    Chu V, American Association of Oral and Maxillofacial Surgeons, American Dental Association.
    Hawaii Dent J; 2008 Sep; 39(5):9-12; quiz 17. PubMed ID: 19189512
    [Abstract] [Full Text] [Related]

  • 20. Osteonecrosis of the jaws: maxillofacial recommendations for bisphosphonate prescribers.
    Landis BN, Dojcinovic I, Richter M, Hugentobler M.
    J Intern Med; 2007 Jan; 261(1):101-2. PubMed ID: 17222173
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.